ELYM: Eliem Therapeutics, Inc. Stock

by  •  • Comments Off on ELYM: Eliem Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 114.14
Enterprise Value ($M) 21.02
Book Value ($M) 107.60
Book Value / Share 3.84
Price / Book 1.06
NCAV ($M) 107.39
NCAV / Share 3.83
Price / NCAV 1.06

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 38.92
Current Ratio 38.92

Balance Sheet (mrq) ($M)
Current Assets 110.25
Assets 110.47
Liabilities 2.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -21.47
Net Income -35.12

Cash Flow Statement (mra) ($M)
Cash From Operations -20.60
Cash from Investing 68.98
Cash from Financing 0.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-12 13D/A Ra Capital Management, L.p. 47.50 0.08
02-07 13G/A BML Investment Partners, L.P. 8.50 23.88
11-13 13D/A Ai Eti Llc 18.50 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 115,138 578,443 19.90
2024-04-25 45,053 387,243 11.63
2024-04-24 4,805 103,519 4.64
2024-04-23 2,709 27,131 9.98
2024-04-22 10,168 19,441 52.30

(click for more detail)

Similar Companies
CVAC – CureVac N.V. EGRX – Eagle Pharmaceuticals, Inc.
ELTX – Elicio Therapeutics, Inc. EOLS – Evolus, Inc.
ESPR – Esperion Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io